Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.
about
Aspirin intake and survival after breast cancerCritical Overview on the Benefits and Harms of Aspirin.The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.Analgesic use and sex steroid hormone concentrations in postmenopausal women.Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyEffect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.The role of aspirin in women's healthPotential contribution of aspirin to cancer control programmes.Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health StudyPPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal womenNew Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives.Aspirin use is associated with lower mammographic density in a large screening cohort.Aspirin use and breast cancer risk: a meta-analysis.Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.Maternal smoking during pregnancy and childhood lymphoma: a meta-analysis.[Severe cutaneous drug reactions in children].Tobacco smoking and risk of multiple myeloma: A meta-analysis of 40 observational studies
P2860
Q24604280-413738B2-BF7C-41C7-A85B-C0940171ACB6Q33664298-D3783529-25D3-49C3-8609-E0AB95DAD35BQ33664316-A7E67654-DE02-4332-BECC-90F85FE370BAQ33780860-607C3373-4227-4A99-80A6-BF9853463A06Q33889458-3F4CDF18-648C-4662-9342-02DC31E283D5Q34458235-A6A07EE8-8D22-4CD0-9C6A-5C78BF154F20Q35119642-19CB7C6E-81E5-47B6-934D-439AA73F7865Q35602238-22619CD8-F35B-4088-8355-4A85BC44A726Q36678729-A0E736D9-9F37-42C2-AEE7-5B500C2DEBB6Q36772391-07DF47F2-A53A-4344-9AB8-2AAF6F14101DQ36806255-1834B9CC-444C-44CD-ACB0-AC77DC3B34AEQ36824033-4A7A6ACA-3D39-4F89-B451-75B2E1F283C3Q38550876-7662DFC1-9A17-44D9-8ADE-2799DED35C61Q38551802-88E165EA-67D4-4ADD-8E4F-DCF01AB8A70BQ38786791-60661EFA-702A-406E-BC45-2535B30D0CA2Q39119109-73D1BC06-C819-4E53-891A-5CFFD3CFE3F1Q39710075-71F7EF6B-F204-4C85-823D-DBC6F64B3C15Q41093416-CB9068F6-50D9-43A9-8AF2-06AA42D07DC6Q43061636-42C6FDDC-1D25-446A-B823-39D91DCBD327Q47559699-D8405944-9094-4772-908F-482E8186436DQ49971753-5B55B376-160C-406B-A5CF-696ADD4B46C7Q57904435-65966E81-356E-44F2-9BDE-744966FD8400
P2860
Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Aspirin use and breast cancer ...... nal studies from 2001 to 2005.
@en
Aspirin use and breast cancer ...... nal studies from 2001 to 2005.
@nl
type
label
Aspirin use and breast cancer ...... nal studies from 2001 to 2005.
@en
Aspirin use and breast cancer ...... nal studies from 2001 to 2005.
@nl
prefLabel
Aspirin use and breast cancer ...... nal studies from 2001 to 2005.
@en
Aspirin use and breast cancer ...... nal studies from 2001 to 2005.
@nl
P2093
P2860
P356
P1476
Aspirin use and breast cancer ...... nal studies from 2001 to 2005.
@en
P2093
Maria Blettner
Peter Schlattmann
Sandra Mangiapane
P2860
P304
P356
10.1002/PDS.1503
P577
2008-02-01T00:00:00Z